QIAGEN’s newly launched digital PCR Microbial DNA Detection Assays can be a timely response to public health crises like infectious disease outbreaks as they enable the precise and sensitive ...

QIAGEN N.V. QGEN recently launched its QIAcuityDx Digital PCR System, whose instrument and accessories are Food and Drug Administration (“FDA”) 510(k) approved and In Vitro Diagnostic ...

Preparing for 2020 launch of novel digital PCR systems with fully integrated workflow and menu of QIAGEN assays, advantages of improved multiplexing, throughput and scalability January 07, 2019 02 ...

FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...

Qiagen N.V. (NYSE: QGEN) ranks among the best CRISPR stocks to buy. Qiagen N.V. (NYSE:QGEN) and Gencurix announced a ...

QIAGEN's QIAcuity digital PCR platform utilizes nanoplates to disperse a sample into thousands of tiny partitions and then reads the reaction in each one simultaneously to quantify even the ...

On Friday, Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to expand the availability of digital polymerase chain ...

Qiagen N.V., a Netherlands-based holding company, is the leading global provider of sample to insight solutions, announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its ...

QIAGEN N.V. has announced that it has acquired licenses from Roche, as well as from Ortho Clinical Diagnostics. These two license agreements significantly expand QIAGEN's rights to real-time ...

Qiagen’s NeuMoDx instruments combine nucleic acid extraction, amplification and detection on a single machine. The company sells a COVID-19 PCR test that can be run on the device, as well as ...